Trials / Recruiting
RecruitingNCT06976164
Reflexo Therapy for Gestational Diabetes Mellitus
The Effects of Reflexo Therapy of Sole on Gestational Diabetes Mellitus
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- Sponsor
- Kafrelsheikh University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study will be to detect the effects of Reflexo therapy of sole on GDM.
Detailed description
Gestational diabetes mellitus is considered a hazard factor for antenatal complications for both mother and fetus. It is characterized by glucose intolerance of variable degrees with the beginning or first recognition of pregnancy. It affects 14% of pregnancies worldwide, and it undergoes continuous changes in the diagnostic criteria, ethnicity and the population studied. There is an increasing prevalence of diabetes mellitus, and its major metabolic disorder caused by the insulin secretion defect or insulin action defect resulting from a defect in insulin secretion, insulin action, or both. As a result, it will lead to chronic hyperglycemia associated with carbohydrates, protein, and fat disturbance. In spite of the fact that the reason for gestational diabetes mellitus is still not fully understood, it is proposed that human placental lactogen has growth hormone-like actions, and that it causes lipolysis and thus increases the levels of circulating fatty acids that repress the action of insulin and cause insulin resistance in pregnant females which appear to play a crucial role in the pathogenesis of gestational diabetes mellitus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | The standard antenatal care. | Antenatal Protocol. |
| PROCEDURE | Foot reflexology. | A manual therapy technique. |
Timeline
- Start date
- 2025-05-01
- Primary completion
- 2026-01-01
- Completion
- 2026-06-01
- First posted
- 2025-05-16
- Last updated
- 2025-05-16
Locations
2 sites across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06976164. Inclusion in this directory is not an endorsement.